Download PDF
Semin Respir Crit Care Med 2007; 28(1): 121-127
DOI: 10.1055/s-2007-970337
Copyright © 2007 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA.

Quality of Life and Health Status in Sarcoidosis: A Review

Jolanda De Vries1 , 3 , Marjolein Drent2 , 3
  • 1Department of Medical Psychology, Tilburg University and St. Elisabeth Hospital, Tilburg, The Netherlands
  • 2Department of Respiratory Medicine, University Hospital Maastricht, The Netherlands
  • 3Sarcoidosis Management Centre, University Hospital Maastricht, The Netherlands
Further Information

Publication History

Publication Date:
28 February 2007 (online)

    Permissions and Reprints

ABSTRACT

The aim of this review is to provide information on the influence of sarcoidosis on patients' quality of life (QOL) and health status (HS), a related concept. A search in the PubMed database was performed with the key words sarcoidosis and health status and sarcoidosis and quality of life. After removing double hits, reviews, articles written in a language other than English or Dutch, guidelines, articles focusing on questionnaire development or validation, and articles in which QOL or HS was not assessed, 28 articles were left for inclusion in the present review. The HS and QOL of sarcoidosis patients is negatively affected by the disease. Symptoms have an additional negative impact on patients' lives. Sarcoidosis has a substantial impact on patients' HS and QOL. Present observational studies all have a cross-sectional design. Prospective longitudinal follow-up studies are lacking, which makes inferences about cause and consequences difficult.

KEYWORDS

Sarcoidosis - quality of life - health status - review

REFERENCES

  • 1 Loddenkemper R, Kloppenborg A, Schoenfeld N, Grosser H, Costabel U. Clinical findings in 715 patients with newly detected pulmonary sarcoidosis-results of a cooperative study in former West Germany and Switzerland. WATL Study Group. Wissenschaftliche Arbeitsgemeinschaft fur die Therapie von Lungenkrankheitan.  Sarcoidosis Vasc Diffuse Lung Dis. 1998;  15 178-182
    PubMedGoogle Scholar
  • 2 Klonoff E A, Kleinhenz M E. Psychological factors in sarcoidosis: the relationship between life stress and pulmonary function.  Sarcoidosis. 1993;  10 118-124
    PubMedGoogle Scholar
  • 3 Hoitsma E, Marziniak M, Faber C G et al.. Small fiber neuropathy in sarcoidosis.  Lancet. 2002;  359 2085-2086
    CrossrefPubMedGoogle Scholar
  • 4 Wirnsberger R M, De Vries J, Wouters E F, Drent M. Clinical presentation of sarcoidosis in the Netherlands: an epidemiological study.  Neth J Med. 1998;  53 53-60
    CrossrefPubMedGoogle Scholar
  • 5 Drent M, Wirnsberger R M, Breteler M H, Kock L M, De Vries J, Wouters E F. Quality of life and depressive symptoms in patients suffering from sarcoidosis.  Sarcoidosis Vasc Diffuse Lung Dis. 1998;  15 59-66
    PubMedGoogle Scholar
  • 6 Wirnsberger R M, De Vries J, Breteler M H, Van Heck G L, Wouters E F, Drent M. Evaluation of quality of life in sarcoidosis patients.  Respir Med. 1998;  92 750-756
    CrossrefPubMedGoogle Scholar
  • 7 De Vries J. Quality of life assessment. In: Vingerhoets AJJM Assessment in Behavioural Medicine. Hove, UK; Brunner-Routledge 2001: 353-370
    Google Scholar
  • 8 WHO .The First Ten Years of the World Health Organisation. Geneva, Switzerland; WHO 1958
    Google Scholar
  • 9 Van der Steeg A F, De Vries J, Roukema J A. Quality of life and health status in breast carcinoma.  Eur J Surg Oncol. 2004;  30 1051-1057
    CrossrefPubMedGoogle Scholar
  • 10 Curtis J R, Patrick D L. The assessment of health status among patients with COPD.  Eur Respir J Suppl. 2003;  41 36s-45s
    PubMedGoogle Scholar
  • 11 De Vries J, Drent M. Quality of life and health status in interstitial lung diseases.  Curr Opin Pulm Med. 2006;  12 E354-E358
    PubMedGoogle Scholar
  • 12 De Vries J, Wirnsberger R M. Fatigue, quality of life, and health status in sarcoidosis.  Eur Respir Monograph. 2005;  10 92-104
    PubMedGoogle Scholar
  • 13 Breek J C, De Vries J, Van Heck G L, Van Berge Henegouwen D P, Hamming J F. Assessment of disease impact in patients with intermittent claudication: discrepancy between health status and quality of life.  J Vasc Surg. 2005;  41 443-450
    CrossrefPubMedGoogle Scholar
  • 14 Fitzpatrick R, Fletcher A, Gore S, Jones D, Spiegelhalter D, Cox D. Quality of life measures in health care, I: Applications and issues in assessment.  BMJ. 1992;  305 1074-1077
    CrossrefPubMedGoogle Scholar
  • 15 Jones P W, Quirk F H, Baveystock C M. The St. George's Respiratory Questionnaire.  Respir Med. 1991;  85 25-31
    CrossrefPubMedGoogle Scholar
  • 16 WHOQOL group .Field Trial WHOQOL-100 February 1995: Facet Definitions and Questions. Geneva, Switzerland; WHO 1995
    Google Scholar
  • 17 WHOQOL group . The World Health Organization Quality of Life assessment (WHOQOL): Position paper from the World Health Organization.  Soc Sci Med. 1995;  41 1403-1409
    CrossrefPubMedGoogle Scholar
  • 18 O'Carroll R E, Cossar J A, Couston M C, Hayes P C. Sensitivity to change following liver transplantation: a comparison of three instruments that measure quality of life.  J Health Psychol. 2000;  5 69-74
    PubMedGoogle Scholar
  • 19 WHOQOL group . The World Health Organisation Quality of Life assessment (WHOQOL): development and general psychometric properties.  Soc Sci Med. 1998;  46 1569-1585
    CrossrefPubMedGoogle Scholar
  • 20 De Vries J. Beyond Health Status: Construction and Validation of the Dutch WHO Quality of Life Instrument. Tilburg, the Netherlands; Tilburg University 1996
    Google Scholar
  • 21 Bergner M, Bobbitt R A, Carter W B, Gilson B S. The Sickness Impact Profile: development and final revision of a health-status measure.  Med Care. 1981;  19 787-805
    CrossrefPubMedGoogle Scholar
  • 22 Bowling A. Measuring Disease: A Review of Disease-Specific Quality of Life Measurement Scales. Buckingham; Open University Press 1995
    Google Scholar
  • 23 Ware Jr J E, Snow K K, Gandek B. SF-36 Health Survey. Manual and Interpretation Guide. Boston; The Health Institute, New England Medical Center 1993
    Google Scholar
  • 24 Chang J A, Curtis J R, Patrick D L, Raghu G. Assessment of health-related quality of life in patients with interstitial lung disease.  Chest. 1999;  116 1175-1182
    CrossrefPubMedGoogle Scholar
  • 25 Guyatt G H, Berman L B, Townsend M, Pugsley S O, Chambers L W. A measure of quality of life for clinical trials in chronic lung disease.  Thorax. 1987;  42 773-778
    CrossrefPubMedGoogle Scholar
  • 26 Guyatt G H, Townsend M, Keller J, Singer J, Nogradi S. Measuring functional status in chronic lung disease: conclusions from a randomised control trial.  Respir Med. 1989;  83 293-297
    CrossrefPubMedGoogle Scholar
  • 27 Wijkstra P J, Ten Vergert E M, Van Altena R et al.. Reliability and validity of the chronic respiratory questionnaire (CRQ).  Thorax. 1994;  49 465-467
    CrossrefPubMedGoogle Scholar
  • 28 Jones P W, Quirk F H, Baveystock C M, Littlejohns P. A self-complete measure of health status for chronic airflow limitation: the St George's Respiratory Questionnaire.  Am Rev Respir Dis. 1992;  145 1321-1327
    CrossrefPubMedGoogle Scholar
  • 29 Jones P W, Bosh T K. Quality of life changes in COPD patients treated with salmeterol.  Am J Respir Crit Care Med. 1997;  155 1283-1289
    PubMedGoogle Scholar
  • 30 Jones P W. Nedocromil Sodium Quality of Life Study Group . Quality of life, symptoms and pulmonary function in asthma: long-term treatment with nedocromil sodium examined in a controlled multicentre trial.  Eur Respir J. 1994;  7 55-62
    CrossrefPubMedGoogle Scholar
  • 31 Cox C E, Donohue J F, Brown C D, Kataria Y P, Judson M A. The Sarcoidosis Health Questionnaire: a new measure of health-related quality of life.  Am J Respir Crit Care Med. 2003;  168 323-329
    CrossrefPubMedGoogle Scholar
  • 32 Kuyken W, Orley J, Hudelson P, Sartorius N. Quality of life assessment across cultures.  Internat J Mental Health. 1994;  23 5-27
    PubMedGoogle Scholar
  • 33 Floor S, Overbeke A JPM. Non-Dutch questionnaires about life quality used in the Dutch Journal for Medicine: translation procedure and arguments for choice of a questionnaire [in Dutch].  Ned Tijdschr Geneeskd. 2006;  150 1724-1727
    PubMedGoogle Scholar
  • 34 De Vries J, Van Heck G L, Drent M. Gender differences in sarcoidosis: symptoms, quality of life, and medical consumption.  Women Health. 1999;  30 99-114
    PubMedGoogle Scholar
  • 35 Hoitsma E, De Vries J, Van Santen-Hoeufft M, Faber C G, Drent M. Impact of pain in a Dutch sarcoidosis patient population.  Sarcoidosis Vasc Diffuse Lung Dis. 2003;  20 33-39
    PubMedGoogle Scholar
  • 36 Wirnsberger R M, De Vries J, Jansen T L, Van Heck G L, Wouters E F, Drent M. Impairment of quality of life: rheumatoid arthritis versus sarcoidosis.  Neth J Med. 1999;  54 86-95
    CrossrefPubMedGoogle Scholar
  • 37 Michielsen H J, Peros-Golubicic T, Drent M, De Vries J. Relationship between symptoms and quality of life in a sarcoidosis population.  Respiration. 2006, Apr 7;  , [Epub ahead of print]
    PubMedGoogle Scholar
  • 38 De Vries J, Drent M, Van Heck G L, Wouters E FM. Quality of life in sarcoidosis: a comparison between members of a patient organization and a random sample.  Sarcoidosis Vasc Diffuse Lung Dis. 1998;  15 183-188
    PubMedGoogle Scholar
  • 39 Wirnsberger R M, Drent M, Hekelaar N et al.. Relationship between respiratory muscle function and quality of life in sarcoidosis.  Eur Respir J. 1997;  10 1450-1455
    CrossrefPubMedGoogle Scholar
  • 40 Antoniou K M, Tzanakis N, Tzouvelekis A et al.. Quality of life in patients with active sarcoidosis in Greece.  Eur J Intern Med. 2006;  17 421-426
    CrossrefPubMedGoogle Scholar
  • 41 Spruit M A, Thomeer M J, Gosselink R et al.. Skeletal muscle weakness in patients with sarcoidosis and its relationship with exercise intolerance and reduced health status.  Thorax. 2005;  60 32-38
    CrossrefPubMedGoogle Scholar
  • 42 Cox C E, Donohue J F, Brown C D, Kataria Y P, Judson M A. Health-related quality of life of persons with sarcoidosis.  Chest. 2004;  125 997-1004
    CrossrefPubMedGoogle Scholar
  • 43 Chang B, Steimel J, Moller D R et al.. Depression in sarcoidosis.  Am J Respir Crit Care Med. 2001;  163 329-334
    CrossrefPubMedGoogle Scholar
  • 44 De Vries J, Drent M. Relationship between perceived stress and sarcoidosis in a Dutch patient population.  Sarcoidosis Vasc Diffuse Lung Dis. 2004;  21 57-63
    PubMedGoogle Scholar
  • 45 Yeager H, Rossman M D, Baughman R P et al.. Pulmonary and psychosocial findings at enrollment in the ACCESS study.  Sarcoidosis Vasc Diffuse Lung Dis. 2005;  22 147-153
    PubMedGoogle Scholar
  • 46 Baughman R P, Iannuzzi M C, Lower E E et al.. Use of fluticasone in acute symptomatic pulmonary sarcoidosis.  Sarcoidosis Vasc Diffuse Lung Dis. 2002;  19 198-204
    PubMedGoogle Scholar
  • 47 Judson M A, Silvestri J, Hartung C, Byars T, Cox C E. The effects of thalidomide on corticosteroid-dependent pulmonary sarcoidosis.  Sarcoidosis Vasc Diffuse Lung Dis. 2006;  23 51-57
    PubMedGoogle Scholar
  • 48 Rabin D L, Richardson M SA, Stein S R, Yeager Jr H. Sarcoidosis severity and socioeconomic status.  Eur Respir J. 2001;  18 499-506
    CrossrefPubMedGoogle Scholar
  • 49 Rabin D L, Thompson B, Brown K M et al.. Sarcoidosis: social predictors of severity at presentation.  Eur Respir J. 2004;  24 601-608
    CrossrefPubMedGoogle Scholar
  • 50 Stavem K, Bjørtuft Ø, Lund M B, Kongshaug K, Geiran O, Boe J. Health-related quality of life in lung transplant candidates and recipients.  Respiration. 2000;  67 159-165
    CrossrefPubMedGoogle Scholar

Jolanda De VriesPh.D. 

Tilburg University, P.O. Box 90153

5000 LE Tilburg, The Netherlands

Email: j.devries@uvt.nl

      >